Pharma Export Grows Over 9% In September

New Delhi: Exports of pharmaceutical products from the country have reported a 9.01 per cent growth during the month of September as compared to the same period of previous year. For the first six months of the current fiscal year, the exports have posted a 5.02 per cent growth.

According to data from the Central Government, the exports during the month of September, 2023 stood at $2.39 billion as compared to $2.19 billion during the same month of last year.

The growth compared to the exports of $2.24 billion in the previous month of August is around 6.7 per cent.

For the six months from April to September, 2023, the exports were at $13.36 billion as compared to $12.72 billion reported during the same period of previous year.

Imports have reported a 3.38 per cent growth during the month of September, at $623.48 million as compared to $603.11 million registered during the same month of last year. The cumulative imports from April to September, 2023 grew marginally to $4.07 billion as compared to $4.06 billion during the same period of previous fiscal year.

The Ministry of Health and Family Welfare in June, this year, said that India’s drug and pharmaceutical products exports grew by 125 per cent from Rs. 90,415 Crore in 2013-14 to Rs. 2,04,110 Crore in 2022-23.

Drugs and Pharmaceuticals exports constitute 5.71 per cent of the total exports from India. India ranks 3rd worldwide for the production of Drugs and Pharmaceuticals by volume exporting to around 200 countries/territories with the top 5 destinations being the USA, Belgium, South Africa, UK, and Brazil.

India accounts for 60 per cent of global vaccine production making it the largest vaccine producer in the world. India is also one of the biggest suppliers of low-cost vaccines in the world and is the largest provider of generic medicines globally, occupying a 20% share in global supply by volume.

“Further, India has supplied over 298 million COVID-19 vaccines to around 100 countries across the globe under Vaccine Maitri initiative (till May 19, 2023),” said the Ministry. It added that an investment of Rs 21,861 crore was received under PLI Schemes till June.

Related Posts

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

Price cap on 2 key cancer drugs increased by 50%

NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

Price cap on 2 key cancer drugs increased by 50%

Price cap on 2 key cancer drugs increased by 50%

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case